Cambridge Health Alliance

Cambridge, Massachusetts 02193

3 studies enrolling now · 29 studies all time

What they study most

AI (Artificial Intelligence), Alcohol Use, Unspecified, Anxiety, Asthma, Autistic Disorder, Behavior Disorders, Behavior Disorders in Children, Behavioral Symptoms, Bereavement, Bipolar Depression, Bipolar Disorder, Colorectal Cancer Screening

Studies at this site

• Improving Mental Health Treatment for Individuals in Crisis Interacting With the Criminal-Legal System — Recruiting now
• Family Connections — Recruiting now
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) — Completed
• Skilled Nursing Facility Care at Home — Running, not enrolling
• Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain — Completed
• OpenEvidence Safety and Comparative Efficacy of Four LLM's in Clinical Practice — Enrolling by invitation
• Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use — Completed
• Community and Familial Impacts of the Opioid Crisis — Completed
• The Safety-Net Approach — Completed
• Effects of RME on Engagement in Buprenorphine Treatment — Completed
• Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings — Completed
• Program for Alleviating and Resolving Trauma and Stress 1 — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• Enhancing Systems of Care: Supporting Families and Improving Youth Outcomes — Completed
• MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE) — Completed
• Evaluation Study for the Efficacy and Safety of PinPointe FootLaser in Treatment for Onychomycosis — Stopped early
• Ropinirole in the Treatment of Bipolar Depression — Completed
• A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder — Completed
• Aripiprazole in the Treatment of Bipolar Depression — Completed
• Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults — Completed
• Study of Patient Navigation to Promote Colon Cancer Screening — Completed
• Natural Supplements for Unipolar Depression — Completed
• Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations — Completed
• A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers — Completed
• Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State — Completed
• A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) — Completed
• A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities — Completed
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder — Completed
• Exploring a Potential Blood Test to Diagnose Major Depressive Disorder — Completed